City

Clinical trials near San Diego, United States

Active studies with a listed research site in San Diego, United States.

21active studies

12recruiting now

11countries represented

55largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 4

A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)

Psoriatic Arthritis, Overweight or ObesityCondition

TirzepatideTreatment

Puerto Rico, United States55 locations

Eli Lilly and CompanySponsor

Updated 2026-09-08 · NCT06864026See eligibility →

Recruiting nowNot applicable

An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being

Excessive Gestational Weight Gain, PregnancyCondition

Intuitive Eating InterventionTreatment

United States2 locations

San Diego State UniversitySponsor

Updated 2026-08-28 · NCT07792837See eligibility →

Recruiting nowNot applicable

Effects of Watermelon or Low-fat Cookie Consumption on Wellness

Overweight and ObesityCondition

Low-fat cookies, WatermelonTreatment

United States1 locations

San Diego State UniversitySponsor

Updated 2026-08-28 · NCT06323070See eligibility →

Recruiting nowPhase 3

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Obesity or OverweightCondition

Maridebart CafraglutideTreatment

Puerto Rico, United States45 locations

AmgenSponsor

Updated 2026-08-27 · NCT07575399See eligibility →

Recruiting nowNot applicable

Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)

Obesity, Bariatric SurgeryCondition

Modified Vertical Sleeve Gastrectomy (mVSG), Conventional Vertical Sleeve Gastrectomy (cVSG)Treatment

United States2 locations

University of California, IrvineSponsor

Updated 2026-07-14 · NCT06783751See eligibility →

Recruiting nowPhase 2

A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

Overweight or Obesity and Elevated Liver FatCondition

Maridebart cafraglutide, PlaceboTreatment

United States23 locations

AmgenSponsor

Updated 2026-06-18 · NCT07441252See eligibility →

Recruiting nowPhase 2

Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy

Type 2 DiabetesCondition

icovamenib 100 mg, PlaceboTreatment

United States17 locations

Biomea Fusion Inc.Sponsor

Updated 2026-06-15 · NCT07502508See eligibility →

Recruiting nowPhase 3

A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist Use

Nausea and Vomiting, ObesityCondition

Tradipitant, PlaceboTreatment

United States10 locations

Vanda PharmaceuticalsSponsor

Updated 2026-04-20 · NCT07446439See eligibility →

Recruiting nowNot applicable

Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population

Diabetes Mellitus, Type 2, ObesityCondition

Mobile health applicationTreatment

United States1 locations

San Diego State UniversitySponsor

Updated 2025-10-06 · NCT05279729See eligibility →

Recruiting nowNot applicable

Efficacy of Using Mobile Health Applications for Health

Diabetes Mellitus, Type 2, ObesityCondition

Mobile health applicationTreatment

United States1 locations

San Diego State UniversitySponsor

Updated 2025-10-06 · NCT05589155See eligibility →

Recruiting nowNot applicable

Promoting Physical Activity and Fitness Among Underserved Latino Families Living in U.S.-Mexico Border Regions

Obesity Prevention, Heart DiseaseCondition

Physical ActivityTreatment

United States1 locations

San Diego State UniversitySponsor

Updated 2025-10-06 · NCT06596902See eligibility →

Recruiting nowNot applicable

Efficacy of mHealth Applications in Weight Management in a Population Affected by Overweight or Obesity

Overweight and ObesityCondition

HealthiTreatment

United States1 locations

San Diego State UniversitySponsor

Updated 2025-10-02 · NCT05726942See eligibility →

Opening soonPhase 3

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Overweight, ObesityCondition

Zenagamtide, SemaglutideTreatment

United States43 locations

Novo Nordisk A/SSponsor

Updated 2026-08-25 · NCT07668414See eligibility →

Opening soonNot applicable

Continuous Wearable Biometric Monitoring in Adults Undergoing Obesity Treatment (SMART-BMI)

ObesityCondition

Biometric-informed care, Control Arm: Standard CareTreatment

United States1 locations

Jeff ReevesSponsor

Updated 2026-07-30 · NCT07736729See eligibility →

Opening soonPhase 2

Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese

Obesity and OverweightCondition

NA-931, TirzepatideTreatment

Australia, New Zealand17 locations

Biomed Industries, Inc.Sponsor

Updated 2026-03-27 · NCT06732245See eligibility →

Active, not recruitingPhase 2

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Overweight, Type 2 DiabetesCondition

Petrelintide, PlaceboTreatment

United States48 locations

Zealand PharmaSponsor

Updated 2026-08-21 · NCT06926842See eligibility →

Active, not recruitingPhase 3

A Trial of Setmelanotide in Acquired Hypothalamic Obesity

Hypothalamic ObesityCondition

Setmelanotide, PlaceboTreatment

Canada, Germany28 locations

Rhythm Pharmaceuticals, Inc.Sponsor

Updated 2026-08-10 · NCT05774756See eligibility →

Active, not recruitingNot applicable

Effects of Negative Affect in Individuals With Binge Eating Episodes

Bulimia Nervosa, Binge-Eating DisorderCondition

Negative Affect TaskTreatment

United States1 locations

University of California, San DiegoSponsor

Updated 2026-08-03 · NCT03393039See eligibility →

Active, not recruitingPhase 3

A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term

ObesityCondition

CagriSema (Cagrilintide B and Semaglutide I), Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)Treatment

United States46 locations

Novo Nordisk A/SSponsor

Updated 2026-07-24 · NCT07011667See eligibility →

Active, not recruitingPhase 3

A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight and Chronic Low Back Pain

Obesity, OverweightCondition

Retatrutide, PlaceboTreatment

Argentina, Canada40 locations

Eli Lilly and CompanySponsor

Updated 2026-07-23 · NCT07035093See eligibility →

Active, not recruitingPhase 2

Efficacy and Safety of Ribupatide (KAI-9531) Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes

ObesityCondition

Ribupatide, PlaceboTreatment

United States35 locations

KaileraSponsor

Updated 2026-07-15 · NCT07458269See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near San Diego, United States

Current studies

Related cities